Clinical Trial Update: Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Fasiglifam (TAK-875) with Sitagliptin, each added to Metformin, in adults with Type 2 diabetes; the study was terminated and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• fasiglifam (fasiglifam)
• metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED | Results posted: 2015-09-28